Katharina Hopp

4.0k total citations
40 papers, 2.2k citations indexed

About

Katharina Hopp is a scholar working on Genetics, Molecular Biology and Nephrology. According to data from OpenAlex, Katharina Hopp has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 21 papers in Molecular Biology and 9 papers in Nephrology. Recurrent topics in Katharina Hopp's work include Genetic and Kidney Cyst Diseases (32 papers), Renal and related cancers (18 papers) and Biomedical Research and Pathophysiology (9 papers). Katharina Hopp is often cited by papers focused on Genetic and Kidney Cyst Diseases (32 papers), Renal and related cancers (18 papers) and Biomedical Research and Pathophysiology (9 papers). Katharina Hopp collaborates with scholars based in United States, United Kingdom and Canada. Katharina Hopp's co-authors include Peter C. Harris, Vicente E. Torres, Cynthia J. Hommerding, Sandro Rossetti, Christopher J. Ward, Vladimir G. Gainullin, Kristen L. Nowak, Samih H. Nasr, Vickie Kubly and Xiaofang Wang and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Scientific Reports.

In The Last Decade

Katharina Hopp

38 papers receiving 2.1k citations

Peers

Countries citing papers authored by Katharina Hopp

Since Specialization

Citations

This map shows the geographic impact of Katharina Hopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Hopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Hopp more than expected).

Fields of papers citing papers by Katharina Hopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Hopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Hopp. The network helps show where Katharina Hopp may publish in the future.

Co-authorship network of co-authors of Katharina Hopp

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Hopp. A scholar is included among the top collaborators of Katharina Hopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Hopp. Katharina Hopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease 2025 ·Kidney360 ·Christopher Y. Chen, Mohamad Hadla, (unknown), Sonu Kashyap, (unknown), (unknown), Whitney Besse, Katharina Hopp, Peter C. Harris, Vishal Patel, Eduardo N. Chini, Mahdi Salih, Michael A. Barry, Fouad T. Chebib	0
2	Renal tissue-resident macrophages promote cystogenesis in early polycystic kidney disease 2025 ·Journal of Cell Science ·(unknown), Azhaar Ashraf, Maria Francesca Viola, Katharina Hopp, Elvira Mass, Dagmar Wachten	0
3	Upregulation of complement proteins in lung cancer cells mediates tumor progression 2023 ·Frontiers in Oncology ·Emily K. Kleczko, Joanna M. Poczobutt, Andre Navarro, Jennifer Laskowski, Amber M. Johnson, (unknown), (unknown), Lynn E. Heasley, Katharina Hopp, Mary C. Weiser-Evans, Elizabeth B. Gottlin, (unknown), Michael J. Campa, Edward F. Patz, Joshua M. Thurman, Raphael A. Nemenoff	6
4	Immune checkpoint activity regulates polycystic kidney disease progression 2023 ·JCI Insight ·Emily K. Kleczko, (unknown), (unknown), (unknown), (unknown), (unknown), Michael Berger, Seth B. Furgeson, Berenice Y. Gitomer, Michel B. Chonchol, Eric T. Clambey, Kurt A. Zimmerman, Raphael A. Nemenoff, Katharina Hopp	9
5	Endocannabinoid System in Polycystic Kidney Disease 2022 ·American Journal of Nephrology ·Jost Klawitter, Cristina Sempio, (unknown), (unknown), Katharina Hopp, Michel Chonchol, Berenice Y. Gitomer, Uwe Christians	5
6	Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease 2022 ·American Journal of Physiology-Renal Physiology ·Katharina Hopp, Emily K. Kleczko, Berenice Y. Gitomer, Michel Chonchol, Jost Klawitter, (unknown), Uwe Christians, Jelena Klawitter	21
7	The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression 2022 ·JCI Insight ·(unknown), Emily K. Kleczko, Nidhi Dwivedi, (unknown), Berenice Y. Gitomer, Michel B. Chonchol, Eric T. Clambey, Raphael A. Nemenoff, Jost Klawitter, Katharina Hopp	13
8	Kynurenines in polycystic kidney disease 2022 ·Journal of Nephrology ·Jost Klawitter, (unknown), (unknown), Katharina Hopp, Michel Chonchol, Berenice Y. Gitomer, Melissa A. Cadnapaphornchai, Uwe Christians, Jelena Klawitter	11
9	Cancer Cell-Specific Major Histocompatibility Complex II Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment 2021 ·Journal of Thoracic Oncology ·Amber M. Johnson, Jennifer M. Boland, Julia Wrobel, (unknown), Mary C. Weiser-Evans, Katharina Hopp, Lynn E. Heasley, Eric T. Clambey, Kimberly R. Jordan, Raphael A. Nemenoff, Erin L. Schenk	21
10	Role of chemokines, innate and adaptive immunity 2020 ·Cellular Signalling ·Kurt A. Zimmerman, Katharina Hopp, Michal Mrug	39
11	Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease 2020 ·Clinical Journal of the American Society of Nephrology ·Kristen L. Nowak, Katharina Hopp	81
12	Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease 2020 ·Cellular Signalling ·(unknown), (unknown), Carolyn Nicole Brown, Sara J. Holditch, (unknown), Andrew Thorburn, Katharina Hopp, Charles L. Edelstein	18
13	Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC 2019 ·Life Science Alliance ·Bonnie Bullock, Abigail K. Kimball, Joanna M. Poczobutt, Alexander Neuwelt, Howard Li, Amber M. Johnson, Jeff Kwak, Emily K. Kleczko, Rachael E. Kaspar, (unknown), Katharina Hopp, Erin L. Schenk, Mary C. Weiser-Evans, Eric T. Clambey, Raphael A. Nemenoff	39
14	Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease 2019 ·Kidney International ·Katharina Hopp, Émilie Cornec-Le Gall, Sarah R. Senum, Iris te Paske, (unknown), Sravanthi Lavu, Saurabh Baheti, Marie E. Edwards, Charles D. Madsen, Christina M. Heyer, Albert Ong, Kyongtae T. Bae, Richard Fatica, Theodore I. Steinman, Arlene B. Chapman, Berenice Y. Gitomer, Ronald D. Perrone, Frederic F. Rahbari-Oskoui, Vicente E. Torres, Peter C. Harris	49
15	Characterization of three ciliopathy pedigrees expands the phenotype associated with biallelic C2CD3 variants 2018 ·European Journal of Human Genetics ·Nicole J. Boczek, Katharina Hopp, (unknown), Daniel Kraft, Margot A. Cousin, Patrick R. Blackburn, Charles D. Madsen, Gavin R. Oliver, Asha Nair, Jie Na, Diana W. Bianchi, (unknown), Peter C. Harris, Pavel N. Pichurin, Eric W. Klee	17
16	Food Restriction Ameliorates the Development of Polycystic Kidney Disease 2015 ·Journal of the American Society of Nephrology ·Gina Warner, Kyaw Zaw Hein, Verónica Nin, (unknown), Claudia C.S. Chini, Katharina Hopp, Peter C. Harris, Vicente E. Torres, Eduardo N. Chini	132
17	Tolvaptan plus Pasireotide Shows Enhanced Efficacy in a PKD1 Model 2014 ·Journal of the American Society of Nephrology ·Katharina Hopp, Cynthia J. Hommerding, Xiaofang Wang, Hong Ye, Peter C. Harris, Vicente E. Torres	96
18	Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families 2013 ·Kidney International ·(unknown), Mark Consugar, (unknown), Jamie L. Sundsbak, Christina M. Heyer, Sandro Rossetti, Vickie Kubly, Katharina Hopp, Vicente E. Torres, Eliécer Coto, Maurizio Clementi, Nadja Bogdanova, Edgar Almeida, Daniel G. Bichet, Peter C. Harris	25
19	Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity 2012 ·Journal of Clinical Investigation ·Katharina Hopp, Christopher J. Ward, Cynthia J. Hommerding, Samih H. Nasr, (unknown), Vladimir G. Gainullin, Sandro Rossetti, Vicente E. Torres, Peter C. Harris	294
20	Identification of Gene Mutations in Autosomal Dominant Polycystic Kidney Disease through Targeted Resequencing 2012 ·Journal of the American Society of Nephrology ·Sandro Rossetti, Katharina Hopp, Robert Sikkink, Jamie L. Sundsbak, (unknown), Vickie Kubly, Bruce W. Eckloff, Christopher J. Ward, Christopher G. Winearls, Vicente E. Torres, Peter C. Harris	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact